Is Kainate Receptor Dysfunction at the Core of Multiple Sclerosis Neuropathology?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1139180

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Multiple Sclerosis (MS) is a devastating disease. The current treatments for MS are not able to prevent the death of cells in the brain and are not able to prevent disability in MS patients. I have identified a family of genes that I predict are responsible for cell death in MS. I will determine what these genes do in the brain. My aim is to identify a target for new treatments to prevent cell death in MS.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

multiple sclerosis (MS) | oligodendrocytes | receptor signalling | stem cells | transgenic animals

Related Links